ZUCCHI, DINA
 Distribuzione geografica
Continente #
NA - Nord America 404
EU - Europa 225
AS - Asia 151
AF - Africa 31
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 814
Nazione #
US - Stati Uniti d'America 401
IT - Italia 83
CN - Cina 74
SE - Svezia 66
SG - Singapore 60
DE - Germania 30
CI - Costa d'Avorio 19
BG - Bulgaria 15
SN - Senegal 10
GB - Regno Unito 7
AT - Austria 6
FI - Finlandia 6
IN - India 6
HK - Hong Kong 4
VN - Vietnam 4
BE - Belgio 3
CA - Canada 3
LT - Lituania 3
TR - Turchia 3
CO - Colombia 2
CZ - Repubblica Ceca 2
NG - Nigeria 2
PL - Polonia 2
EU - Europa 1
RO - Romania 1
RU - Federazione Russa 1
Totale 814
Città #
Santa Clara 103
Chandler 59
Shanghai 43
Singapore 39
Boardman 31
Florence 25
Abidjan 19
Ashburn 18
Munich 18
Fairfield 17
Seattle 16
Sofia 15
New York 14
Dakar 10
Houston 10
Wilmington 10
Bremen 9
Lawrence 9
Livorno 9
Pisa 9
Princeton 9
Milan 8
Ogden 7
San Diego 6
Vienna 6
Woodbridge 6
Fuzhou 5
Helsinki 5
La Spezia 5
Cambridge 4
Hong Kong 4
Medford 4
Montecatini Terme 4
Ann Arbor 3
Beijing 3
Bologna 3
Brussels 3
Frankfurt am Main 3
Hyderabad 3
Istanbul 3
London 3
Pune 3
Quanzhou 3
Brno 2
Dong Ket 2
Hangzhou 2
Lagos 2
Norwalk 2
Reggio Emilia 2
Toronto 2
Warsaw 2
Xiamen 2
Bogotá 1
Cluj-Napoca 1
Gallarate 1
Kent 1
Ottawa 1
Padova 1
Redmond 1
Rome 1
Totale 612
Nome #
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience 90
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare 72
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus 69
Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus. 66
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology? 66
Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study 59
Translation, cultural adaptation and validation of the Italian version of the Brief Index of Lupus Damage: the BILDit 58
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort 50
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies 47
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 40
Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches. 38
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study. 27
Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use? 27
Gender differences in SLE: report from a cohort of 417 Caucasian patients. 24
Environment and systemic lupus erythematosus. 21
Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort. 18
Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream. 17
Patient Care Pathways for Pregnancy in Rare and Complex Rheumatic Diseases: Results From an International Survey. 17
Exploring patient's experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach. 16
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes. 14
Adherence to medication during pregnancy in systemic autoimmune diseases: results from a prospective study. 13
Treatment With Anifrolumab for Discoid Lupus Erythematosus. 12
Totale 861
Categoria #
all - tutte 3.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 5 4 4 3 3 2
2020/202132 0 2 0 0 0 0 18 0 7 1 0 4
2021/202289 7 2 0 4 14 18 4 4 0 8 13 15
2022/2023214 23 29 14 14 25 18 1 20 51 1 15 3
2023/2024188 6 8 7 1 14 24 45 9 2 0 36 36
2024/2025317 12 22 45 36 72 101 29 0 0 0 0 0
Totale 861